CAIP(SH:603035)2023-04-27 16:00Financial Performance - The company's operating revenue for Q1 2023 was CNY 844,899,369.28, representing a year-on-year increase of 23.85%[4] - The net profit attributable to shareholders was CNY 92,022,010.67, reflecting a growth of 16.97% compared to the same period last year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 76,887,586.93, up by 19.25% year-on-year[4] - Total operating revenue for Q1 2023 reached ¥844,899,369.28, an increase of 24% compared to ¥682,169,934.28 in Q1 2022[18] - Net profit for Q1 2023 was ¥91,524,927.00, representing a 20% increase from ¥76,049,479.82 in Q1 2022[20] - The company reported a total comprehensive income of ¥91,522,216.11 for Q1 2023, compared to ¥76,049,479.82 in Q1 2022, showing a 20% increase[21] - Earnings per share for Q1 2023 were ¥0.24, compared to ¥0.22 in Q1 2022, indicating a growth of 9%[21] Cash Flow and Liquidity - The net cash flow from operating activities decreased significantly by 90.68%, amounting to CNY 15,982,479.39[4] - The company reported a net cash outflow from operating activities of ¥246,783,290.41, compared to a net outflow of ¥121,191,287.51 in Q1 2022[31] - Cash and cash equivalents were reported at ¥461,206,906.90, down from ¥731,243,822.48, representing a significant decrease of approximately 37.03%[13] - Cash and cash equivalents at the end of Q1 2023 stood at ¥187,644,867.56, down from ¥384,195,199.74 at the end of Q1 2022, indicating a decrease of 51.1%[23] - The company's cash inflow from financing activities was ¥564,413,754.29, an increase from ¥480,972,775.30 in Q1 2022, reflecting a growth of 17.4%[23] - The company’s cash outflow for financing activities increased to ¥604,680,781.46 from ¥494,440,782.87, marking a rise of 22.3%[23] Assets and Liabilities - The total assets at the end of the reporting period were CNY 8,640,463,723.26, an increase of 1.20% from the end of the previous year[4] - Total liabilities as of Q1 2023 amounted to ¥3,911,933,189.75, slightly up from ¥3,901,223,546.97 in the previous year[16] - The company's total liabilities decreased to ¥1,462,849,073.52 from ¥1,721,742,130.53, representing a reduction of 15.0%[25] - The total cash inflow from investment activities was ¥256,296,415.19, compared to ¥234,012,763.10 in Q1 2022, indicating a growth of 9.5%[32] Research and Development - Research and development expenses rose by 42.56%, driven by increased personnel costs and expenses related to new technology development[7] - Research and development expenses increased to ¥35,825,842.76 in Q1 2023, up from ¥25,130,634.11 in Q1 2022, marking a 43% rise[20] - Research and development expenses decreased to ¥2,033,477.98 in Q1 2023 from ¥3,043,330.41 in Q1 2022, a reduction of 33.2%[28] Operational Costs - Total operating costs for Q1 2023 were ¥780,674,610.15, up from ¥630,949,225.45 in Q1 2022, reflecting a 24% increase[18] - The company reported a significant increase in sales expenses by 83.87%, attributed to new overseas operations[7] - Financial expenses for Q1 2023 were ¥11,738,162.74, a decrease from ¥12,858,756.81 in Q1 2022[20] - Financial expenses decreased to ¥3,983,181.69 in Q1 2023 from ¥5,222,339.09 in Q1 2022, a decline of 23.7%[28] Investments - The cash flow from investment activities increased by 634.22%, due to new factory constructions and expansions[7] - The company achieved an investment income of ¥30,701,071.22 in Q1 2023, slightly down from ¥31,064,382.48 in Q1 2022[28] - The company's long-term equity investments were valued at ¥2,077,376,652.74, a slight increase from ¥2,050,487,859.23, indicating a growth of approximately 1.30%[14] - The company’s long-term equity investments rose slightly to ¥3,092,283,114.70 from ¥3,061,582,043.48, an increase of 1.0%[24] Miscellaneous - The company has not disclosed any significant new product developments or market expansion strategies in the current report[12] - There are no significant changes in shareholder structure or related party transactions reported for the period[11]